Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160


Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.

McCowan C, Munro AJ, Donnan PT, Steele RJ.

Eur J Cancer. 2013 Mar;49(5):1049-57. doi: 10.1016/j.ejca.2012.10.024. Epub 2012 Nov 19.


Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study.

Fraser DM, Sullivan FM, Thompson AM, McCowan C.

Br J Cancer. 2014 Jul 29;111(3):623-7. doi: 10.1038/bjc.2014.264. Epub 2014 Jun 19.


Post-operative aspirin use and colorectal cancer-specific survival in patients with stage I-III colorectal cancer.

Goh CH, Leong WQ, Chew MH, Pan YS, Tony LK, Chew L, Tan IB, Toh HC, Tang CL, Fu WP, Chia WK.

Anticancer Res. 2014 Dec;34(12):7407-14. Erratum in: Anticancer Res. 2015 Feb;35(2):1219. Goh, Hin Hock [corrected to Goh, Chin Hock].


Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer.

Macfarlane TV, Murchie P, Watson MC.

Cancer Epidemiol. 2015 Dec;39(6):1015-22. doi: 10.1016/j.canep.2015.10.030. Epub 2015 Nov 18.


Aspirin use and survival after diagnosis of colorectal cancer.

Chan AT, Ogino S, Fuchs CS.

JAMA. 2009 Aug 12;302(6):649-58. doi: 10.1001/jama.2009.1112.


Response to letter commenting on paper EJC-D-12-01401: Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.

McCowan C, Donnan PT, Munro AJ, Steele RJ.

Eur J Cancer. 2013 Jun;49(9):2273. doi: 10.1016/j.ejca.2013.03.012. Epub 2013 Mar 27. No abstract available.


Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study.

Walker AJ, Grainge MJ, Card TR.

Br J Cancer. 2012 Oct 23;107(9):1602-7. doi: 10.1038/bjc.2012.427. Epub 2012 Sep 25.


Low-dose aspirin use and cancer characteristics: a population-based cohort study.

Jonsson F, Yin L, Lundholm C, Smedby KE, Czene K, Pawitan Y.

Br J Cancer. 2013 Oct 1;109(7):1921-5. doi: 10.1038/bjc.2013.411. Epub 2013 Jul 25.


Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study.

Stürmer T, Glynn RJ, Lee IM, Manson JE, Buring JE, Hennekens CH.

Ann Intern Med. 1998 May 1;128(9):713-20.


Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis.

Zell JA, Ziogas A, Bernstein L, Clarke CA, Deapen D, Largent JA, Neuhausen SL, Stram DO, Ursin G, Anton-Culver H.

Cancer. 2009 Dec 15;115(24):5662-71. doi: 10.1002/cncr.24705.


Use of aspirin postdiagnosis improves survival for colon cancer patients.

Bastiaannet E, Sampieri K, Dekkers OM, de Craen AJ, van Herk-Sukel MP, Lemmens V, van den Broek CB, Coebergh JW, Herings RM, van de Velde CJ, Fodde R, Liefers GJ.

Br J Cancer. 2012 Apr 24;106(9):1564-70. doi: 10.1038/bjc.2012.101. Epub 2012 Mar 27.


The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study.

Huang WK, Chiou MJ, Yu KH, Lin YC, Yang TS, Chen JS, Kuo CF, See LC.

Aliment Pharmacol Ther. 2013 Aug;38(4):432-9. doi: 10.1111/apt.12388. Epub 2013 Jun 25.


Aspirin extends life of some patients with colorectal cancer.

Printz C.

Cancer. 2013 Feb 1;119(3):472-3. doi: 10.1002/cncr.27961. No abstract available.


Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort.

Cardwell CR, Kunzmann AT, Cantwell MM, Hughes C, Baron JA, Powe DG, Murray LJ.

Gastroenterology. 2014 Mar;146(3):700-708.e2. doi: 10.1053/j.gastro.2013.11.005. Epub 2013 Nov 15.


Aspects of survival from colorectal cancer in Denmark.

Iversen LH.

Dan Med J. 2012 Apr;59(4):B4428.


Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studies.

Ye XF, Wang J, Shi WT, He J.

Br J Cancer. 2014 Nov 25;111(11):2172-9. doi: 10.1038/bjc.2014.481. Epub 2014 Sep 2.


The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.

Macarthur M, Sharp L, Hold GL, Little J, El-Omar EM.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1613-8.


Inequalities in survival from colorectal cancer: a comparison of the impact of deprivation, treatment, and host factors on observed and cause specific survival.

Wrigley H, Roderick P, George S, Smith J, Mullee M, Goddard J.

J Epidemiol Community Health. 2003 Apr;57(4):301-9.


Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis.

Huang XZ, Gao P, Sun JX, Song YX, Tsai CC, Liu J, Chen XW, Chen P, Xu HM, Wang ZN.

Cancer Causes Control. 2015 Apr;26(4):589-600. doi: 10.1007/s10552-015-0539-y. Epub 2015 Feb 21.


PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.

Paleari L, Puntoni M, Clavarezza M, DeCensi M, Cuzick J, DeCensi A.

Clin Oncol (R Coll Radiol). 2016 May;28(5):317-26. doi: 10.1016/j.clon.2015.11.008. Epub 2015 Dec 17. Review.


Supplemental Content

Support Center